Another study by the same journal. This one was published yesterday and studies how to best integrate Point of Care Tests (POCT), like FebriDx into clinical practices.
Seems like a lot of work is being done in this area, and LDX seem to have a prime product for centre stage in FebriDx.
Link to study: https://bjgpopen.org/content/early/2024/11/11/BJGPO.2024.0112
Aim:To explore factors that influence the adoption or non-adoption of POCT in English general practices and provide insights to enable its integration into routine practice workflows.
Conclusion:General practices should demonstrate flexibility in the workflow and workforce they deploy to integrate POCT into routine clinical workflow.
- Forums
- ASX - By Stock
- LDX Discussion
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
2.9¢

Another study by the same journal. This one was published...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.70M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.9¢ | $1.912K | 65.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 571666 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 506666 | 0.028 |
3 | 318288 | 0.027 |
2 | 443000 | 0.026 |
6 | 601153 | 0.025 |
1 | 1238229 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 150000 | 1 |
0.031 | 250309 | 3 |
0.032 | 51725 | 1 |
0.033 | 190000 | 1 |
0.034 | 189253 | 1 |
Last trade - 10.42am 20/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |